The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Makatsaria A.D.

Sechenov First Moscow State Medical University, Moscow, Russia

Akin’shina S.V.

Sechenov First Moscow State Medical University, Moscow, Russia

Bitsadze V.O.

Sechenov First Moscow State Medical University, Moscow, Russia

Thrombosis of the cerebral veins in gynecological practice

Authors:

Makatsaria A.D., Akin’shina S.V., Bitsadze V.O.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(8‑2): 33‑39

DOI: 10.17116/jnevro20161168233-39

Read: 1185 times

Download PDF (RU)
Contact the author
Table of contents

THROMBOSIS OF THE CEREBRAL VEINS IN GYNECOLOGICAL PRACTICE
THROMBOSIS OF THE CEREBRAL VEINS IN GYNECOLOGICAL PRACTICE

To cite this article:

Makatsaria AD, Akin’shina SV, Bitsadze VO. Thrombosis of the cerebral veins in gynecological practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(8‑2):33‑39. (In Russ.)
https://doi.org/10.17116/jnevro20161168233-39

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Evaluation of whole blood immu­noreactivity. Piro­gov Russian Journal of Surgery. 2024;(12-2):122-126
Pecu­liarities of placental microRNA expression in patients with preeclampsia and fetal growth restriction. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):14-25
Changes in the type of psychological component of the gestational domi­nant in pregnant women in the third trimester after completing the peri­natal preparation program. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):66-71
Sexual function of women during pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):112-117
Dyna­mics of Substance P and Fila­ggrin Levels on Combined Treatment of Atopic Dermatitis with Emollient and Topi­cal Anti­pruritic Drug in Pregnant Women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):662-666
Functional cyto­kine redu­ndancy in pregnancy. Russian Journal of Human Reproduction. 2024;(6):73-80
Clinical case of successful pregnancy in a patient with ecto­pic ACTH syndrome after radi­cal surgical treatment. Russian Journal of Human Reproduction. 2024;(6):118-123
Diabetic reti­nopathy and pregnancy. Russian Annals of Ophthalmology. 2024;(6):145-151
Correction of the effect of direct oral and pare­nteral anti­coagulants in hemo­rrhagic stroke. Burdenko's Journal of Neurosurgery. 2025;(1):109-115
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Abstract:

The review presents literature data on the risk factors of cerebral venous thrombosis (CVT), a rare life threatening disorder. Currently, the diagnosis of CVT is made more often due to the possibility of using neuroimaging methods of cerebral structures. Pregnancy, postpartum period, use of oral contraceptives are risk factors of CVT. A role of thrombophilia, in particular Factor V Leiden mutations and the prothrombin G20210A polymorphism, in the CVT pathogenesis is confirmed. The development of CVT is an example of the interaction between persistent risk factors increasing the likelihood of thrombotic complications and acquired risk factors. A focal neurological deficit during pregnancy, delivery and postpartum period is the best indicator of CVT diagnosis. Possibilities of the use of anticoagulants in treatment and prevention of CVT are analyzed.

Keywords:

cerebral venous thrombosis
pregnancy
thrombophilia
heparin
low molecular weight heparin
fractionated heparins

Authors:

Makatsaria A.D.

Sechenov First Moscow State Medical University, Moscow, Russia

Akin’shina S.V.

Sechenov First Moscow State Medical University, Moscow, Russia

Bitsadze V.O.

Sechenov First Moscow State Medical University, Moscow, Russia

Close metadata

References:

  1. Kitchens CS, Konkle BA, Kessler СМ. Consultative Hemostasis and Thrombosis (Third Edition). Philadelphiа: Elsivier; 2013.
  2. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352(17):1791-1798. doi: 10.1056/nejmra042354
  3. DeVeber G. In pursuit of evidence-based treatments for paediatric stroke: the UK and Chest guidelines. Lancet Neurol. 2005;4(7):432-436. doi: 10.1016/s1474-4422(05)70120-4
  4. Brey RL, Coull BM. Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutation. Stroke. 1996;27(10):1719-1720. doi:10.1161/01.str.27.10.1719
  5. Deschiens MA, Conard J, Horellou MH, Ameri A, Preter M, Chedru F, Samama MM, Bousser MG. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke. 1996;27(10):1724-1730. doi: 10.1161/01.str.27.10.1724
  6. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338(25):1793-1797. doi: 10.1056/nejm199806183382502
  7. Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood. 2006;107(7):2766-2773. doi: 10.1182/blood-2005-09-3578
  8. Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood. 2003;102(4):1363-1366. doi: 10.1182/blood-2003-02-0443
  9. Passamonti SM, Biguzzi E, Cazzola M, Franchi F, Gianniello F, Bucciarelli P, Pietra D, Mannucci PM, Martinelli I. The JAK2 V617F mutation in patients with cerebral venous thrombosis. J Thromb Haemost. 2012;10(6):998-1003. doi: 10.1111/j.1538-7836.2012.04719.x
  10. Martinelli I. Cerebral vein thrombosis. Thromb Res. 2013;131(suppl 1):51-54. doi: 10.1016/S0049-3848(13)70022-7
  11. Martinelli I, Franchini M, Mannucci PM. How I treat rare venous thromboses. Blood. 200815;112(13):4818-4823. doi: 10.1182/blood-2008-07-165969
  12. Marongiu F, Tosetto A, Palareti G. Special indications for vitamin K antagonists: a review. Intern Emerg Med. 2012;7(1):21-25. doi: 10.1007/s11739-011-0543-5
  13. Dentali F, Squizzato A, Gianni M, De Lodovici ML, Venco A, Paciaroni M, Crowther M, Ageno W. Safety of thrombolysis in cerebral venous thrombosis. A systematic review of the literature. Thromb Haemost. 2010;104(5):1055-1062. doi: 10.1160/TH10-05-0311
  14. Ferro JM, Crassard I, Coutinho JM, Canhão P, Barinagarrementeria F, Cucchiara B, Derex L, Lichy C, Masjuan J,Massaro A, Matamala G, Poli S, Saadatnia M, Stolz E, Viana-Baptista M, Stam J, Bousser MG; Second International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT 2) Investigators. Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of individual patient data. Stroke. 2011;42(10):2825-2831. doi: 10.1161/STROKEAHA.111.615393
  15. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664-670. doi: 10.1161/01.str.0000117571.76197.26
  16. Martinelli I, Bucciarelli P, Passamonti SM, Battaglioli T, Previtali E, Mannucci PM. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis. Circulation. 2010;121(25):2740-2746. doi: 10.1161/CIRCULATIONAHA.109.927046
  17. Chan WS. Venous thromboembolism in pregnancy. Expert Rev Cardiovasc Ther. 2010;8(12):1731-1740. doi: 10.1586/erc.10.169
  18. Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan KS.Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol. 2003;101(6):1319-1332. doi: 10.1016/s0029-7844(03)00169-8
  19. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol. 2005;106(3):509-516. doi: 10.1097/01.aog.0000172428.78411.b0
  20. Warkentin TE. Heparin-induced thrombocytopenia. Hematol Oncol Clin North Am. 2007;21(4):589-607. doi: 10.1201/9780203027363
  21. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106(2):401-407. doi: 10.1182/blood-2005-02-0626
  22. Carlin AJ, Farquharson RG, Quenby SM, Topping J, Fraser WD. Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control. Hum Reprod. 2004;19(5):1211-1214. doi: 10.1093/humrep/deh115
  23. Hills FA, Abrahams VM, González-Timón B, Francis J, Cloke B, Hinkson L, Rai R, Mor G, Regan L, Sullivan M, Lam EW,Brosens JJ. Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod. 2006;12(4):237-243. doi: 10.1093/molehr/gal026
  24. Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, Scarselli GF, Gensini GF, Abbate R. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension. 2005;45(1):86-91. doi: 10.1161/01.hyp.0000149950.05182.a3
  25. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J; American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):844-886. doi: 10.1378/chest.08-0761
  26. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005;2:CD002859. doi: 10.1002/14651858.cd002859.pub2
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.